Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes

被引:22
|
作者
Eastwood, Brian [1 ,2 ]
Strang, John [1 ]
Marsden, John [1 ,2 ]
机构
[1] Kings Coll London, Addict Dept, Inst Psychiat Psychol & Neurosci, Box 48,DeCrespigny Pk,Denmark Hill, London SE5 8AF, England
[2] Publ Hlth England, Hlth Improvement Directorate, Alcohol Drugs Tobacco & Justice Div, 7 Floor,Wellington House,133-155 Waterloo Rd, London SE1 8UG, England
关键词
Treatment effectiveness; Opioid use disorder; National; Developmental trajectory; USE DISORDER; FOLLOW-UP; DRUG; 5-YEAR; REDUCTIONS; ADDICTION; RECOVERY; RISK;
D O I
10.1016/j.drugalcdep.2018.03.052
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: This is the first national study in England of continuous long-term opioid substitution treatment (OST). Methods: All adults were admitted to community OST for opioid use disorder (OUD) in 2008/09 with continuous enrolment to 2013/14 (n = 7719). Heroin use trajectories were identified by multilevel Latent Class Growth Analysis. In Year 6 and 7 of follow-up, the outcome measure (analysed by multilevel, multivariable logistic regression) was 'successful completion and no re-presentation' (SCNR) to community treatment within six months. Results: Five heroin use trajectory classes were identified: 'gradual decreasing' (20.9%), 'decreasing then increasing' (21.7%), 'continued low-level' (17.0%), 'rapid decreasing' (25.6%), and 'continued high-level' (14.8%). At the end of Year 7, 4616 people (60.3%) remained in OST. Of those discharged, 28.8% achieved the SCNR follow-up outcome. SCNR was more likely in the 'gradual decreasing' (adjusted odds ratio [AOR] 2.40; 95% confidence interval [CI] 1.77-3.26), 'continued low-level' (AOR 2.46; CI 1.78-3.40), and 'rapid decreasing' (AOR 3.40; CI 2.43-4.37) classes relative to the 'continued high-level' class. SCNR was more likely among patients employed at admission (AOR 1.45; 95% CI 1.15-1.83) and those receiving adjunctive psychosocial interventions (AOR 1.44; 95% CI 1.03 to 2.02). Conclusions: Among English patients in OST for 5 years, heroin use trajectories were clearly delineated with a gradient of response on the study outcome. Successful completion and no re-presentation was achieved by 28.8% of discharged patients. The rapid decreasing trajectory had the greatest likelihood of positive outcome. Adjunctive psychosocial intervention during OST was associated with positive outcome.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 50 条
  • [21] Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
    Sanger, Nitika
    Bhatt, Meha
    Zielinski, Laura
    Sanger, Stephanie
    Shahid, Hamnah
    Bantoto, Bianca
    Samaan, M. Constantine
    de Souza, Russell
    Samaan, Zainab
    SYSTEMATIC REVIEWS, 2018, 7
  • [22] Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study
    Hartung, Daniel M.
    Markwardt, Sheila
    Johnston, Kirbee
    Geddes, Jonah
    Baker, Robin
    Leichtling, Gillian
    Hildebran, Christi
    Chan, Brian
    Cook, Ryan R.
    McCarty, Dennis
    Ghitza, Udi
    Korthuis, P. Todd
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)
  • [23] Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
    Thakrar, Ashish P.
    Uritsky, Tanya J.
    Christopher, Cara
    Winston, Anna
    Ronning, Kaitlin
    Sigueza, Anna Lee
    Caputo, Anne
    McFadden, Rachel
    Olenik, Jennifer M.
    Perrone, Jeanmarie
    Delgado, M. Kit
    Lowenstein, Margaret
    Compton, Peggy
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [24] The Influence of Anxiety Sensitivity on Opioid Use Disorder Treatment Outcomes
    Baxley, Catherine
    Weinstock, Jeremiah
    Lustman, Patrick J.
    Garner, Annie A.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 27 (01) : 64 - 77
  • [25] The Impact of Chronic Pain on Opioid Use Disorder Treatment Outcomes
    MacLean, R. Ross
    Spinola, Suzanne
    Garcia-Vassallo, Gabriella
    Sofuoglu, Mehmet
    CURRENT ADDICTION REPORTS, 2021, 8 (01) : 100 - 108
  • [26] The Impact of Chronic Pain on Opioid Use Disorder Treatment Outcomes
    R. Ross MacLean
    Suzanne Spinola
    Gabriella Garcia-Vassallo
    Mehmet Sofuoglu
    Current Addiction Reports, 2021, 8 : 100 - 108
  • [27] Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities
    Johnson, Bjorn
    Richert, Torkel
    HARM REDUCTION JOURNAL, 2019, 16 (1)
  • [28] Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT)
    Metrebian, Nicola
    Groshkova, Teodora
    Hellier, Jennifer
    Charles, Vikki
    Martin, Anthea
    Forzisi, Luciana
    Lintzeris, Nicholas
    Zador, Deborah
    Williams, Hugh
    Carnwath, Tom
    Mayet, Soraya
    Strang, John
    ADDICTION, 2015, 110 (03) : 479 - 490
  • [29] Effects of Unemployment on Opioid Use Treatment Trajectories Impact of the COVID-19 Pandemic
    Mumba, Mercy Ngosa
    Davis, Lori
    Smith, Natalia Langer
    Evans, Teairra
    Castillo, Rachael
    JOURNAL OF ADDICTIONS NURSING, 2022, 33 (03) : 168 - 171
  • [30] Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone
    Zhu, Yuhui
    Mooney, Larissa J.
    Yoo, Caroline
    Evans, Elizabeth A.
    Kelleghan, Annemarie
    Saxon, Andrew J.
    Curtis, Megan E.
    Hser, Yih-Ing
    DRUG AND ALCOHOL DEPENDENCE, 2021, 228